MARS Bioimaging Ltd spectral CT for biomedical imaging
MARS Bioimaging Ltd spectral CT for biomedical imaging Anthony Butler www. marsbioimaing. com
Overview Founded 2008: Spin out of University of Canterbury Exclusive licence for CERN Medipix 3 detector technology Own all IP relating spectral CT from the university Products: MARS scanners: Medipix 3 based micro. CT system MARS camera: Medipix 3 detector and readout for integration into 3 rd party CTs
Technology and its uses
Spectral CT is now possible Medipix All Resolution System Energy resolution Spatial resolution MARS spectral CT Temporal resolution Xray source Medipix Color detectors
Low GAG Cartilage Bone
MBI Products
MARS scanner micro. CT for small animal and pathology researcher
MARS Medipix 3 camera system for integration into 3 rd party systems Up to 8 Simultaneous energies 55µm or 110 µm pixel pitch resolution 1 to 6 Medipix chips (28 x 52 mm array) Silicon or Cd. Te/CZT Excellent energy resolution ( Charge sharing compensation ) Image of PCB taken with Medipix 3 Si-quad, 28 x 28 mm
MBI Company information
Market strategy Get MARS systems to key opinion leader’s labs Enable researchers using MARS tool to validate spectral CT Provide camera units for existing pre-clinical manufacturers to integrate into their systems Leverage pre-clinical adoption to find partner for human imaging
MARS project structure MARS is the technology MARS Bioimaging Ltd aka. “MBI” Commercial outlet for NZ’s R+D Research teams University of Canterbury University of Otago
MARS project structure MARS Bioimaging Ltd aka. “MBI” Commercial outlet for NZ’s R+D Shareholders University of Canterbury Individual scientist Private investors
MARS IP structure MARS Bioimaging Ltd All IP relating to spectral CT technology University of Canterbury Sub-contract for pre-clinical research University of Otago Exclusive license for small animal and human CT Medipix 3 Collaboration
MARS Funding structure Investment MARS Bioimaging Ltd University of Canterbury University of Otago Medipix 3 Collaboration
MARS Funding structure Sales Investment MARS Bioimaging Ltd University of Canterbury University of Otago Medipix 3 Collaboration
MARS Funding structure Sales Investment MARS Bioimaging Ltd Scholarship funding University of Canterbury University of Otago Contribution to Medipix 3 development Medipix 3 Collaboration
MARS Funding structure Sales Investment MARS Bioimaging Ltd Scholarship funding University of Canterbury University of Otago Contribution to Medipix 3 development Medipix 3 Collaboration NZ government funding
Why would a researcher do this?
Government instruction 80% of NZ government funding is aimed at economic return Key concept is international revenue Want a route to market early in an R+D program
Benefit to research Provides direction and focus Get the technology into users hands early Provides new funding routes
Personal Satisfaction – your research is used!!! New challenges
Personal Satisfaction – your research is used!!! New challenges Potential for financial gain… …. but I’m a radiologist!!
Summary MARS-CT make spectral CT possible Early adopters already purchasing www. marsbioimaging. com
- Slides: 23